Impact of body mass index on left atrial dimension in HOCM patients

Yue Zhou1,2, Miao Yu1,2, Jingang Cui1

  • 1Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 167 Beilishi Road, Xicheng District, Beijing 100037, China.

Insights

Body mass index (BMI) is linked to left atrial (LA) size in hypertrophic obstructive cardiomyopathy (HOCM). While obesity is associated with LA enlargement, it does not independently predict atrial fibrillation (AF) in HOCM patients.

Area of Science:

  • Cardiology
  • Obesity Research
  • Cardiovascular Disease

Background:

  • Left atrial (LA) enlargement predicts atrial fibrillation (AF).
  • Obesity is a modifiable cardiovascular disease risk factor.
  • The relationship between body mass index (BMI) and LA dimension in hypertrophic obstructive cardiomyopathy (HOCM) is not well understood.

Purpose of the Study:

  • To investigate the association between BMI and LA dimension in HOCM patients.
  • To determine if BMI independently predicts AF in HOCM.

Main Methods:

  • 423 HOCM patients were stratified by BMI into normal weight, overweight, and obesity groups.
  • Statistical analyses included multiple linear regression and multivariable binary logistic regression.
  • LA diameter and AF prevalence were assessed in relation to BMI and other clinical factors.

Main Results:

  • Obesity was associated with lower prevalence of syncope, moderate/severe mitral regurgitation, and lower NT-proBNP levels.
  • BMI, log NT-proBNP, AF presence, and left ventricular diastolic diameter index were independently related to LA diameter.
  • BMI was not an independent predictor of AF prevalence in HOCM patients.

Conclusions:

  • BMI is independently associated with LA diameter in HOCM.
  • BMI does not independently predict AF prevalence in HOCM.
  • Findings suggest BMI may influence AF incidence via LA enlargement in HOCM.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
146
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
144
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.9K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
121
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
169
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
85